SAN DIEGO--(BUSINESS WIRE)--Cytori Therapeutics, Inc. (NASDAQ:CYTX - News) received European approval - CE Mark - for the second generation Celution™ stem and regenerative cell processing system. The Celution™ System is the only device approved in Europe to extract and concentrate a patient’s own stem and regenerative cells from within fat tissue in order to be delivered back to the same patient in the same procedure. Fat tissue, known medically as adipose, is a rich, accessible, and non-embryonic source of stem and regenerative cells.
